Güvener N, Akcan Y, Paksoy I, Soylu A R, Aydin M, Arslan S, Gedik O
Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Exp Clin Endocrinol Diabetes. 1999;107(3):172-6. doi: 10.1055/s-0029-1212093.
Helicobacter pylori (HP) is the most common cause of nonerosive nonspecific gastritis. Gastric and duadenal ulcer both are found to be associated with HP infection. Another consequence of HP infection is that it may progress to chronic atrophic gastritis which is a well recognized risk factor for adenocarcinoma of the stomach. So by extension, HP infection can be accepted as a risk factor for gastric cancer. From this aspect, identification of risk groups is increasingly important. It is well-known that patients with diabetes mellitus are more prone to infection. Besides this, presence of gastroparesis diabeticorum may lead to bacterial overgrowth in the upper gastrointestinal (GI) tract. The present crossectional study was planned to study the presence of HP infection in diabetic patients with alterations in upper GI motility and to compare the results with healthy control group. Group I consisted of 51 patients with type II diabetes mellitus (as defined by National Data Group criteria) without any dyspeptic symptoms. Twenty-five age-matched healthy people served as a control in group II. Radionuclide-labelled solid meals were used to calculate gastric emptying time (GET). According to the results, patients in group I were divided into two groups. Patients with prolonged GET were grouped as group IA, while group IB consisted of patients with normal or shortened GET. Presence of HP gastritis is determined by histopathologic examination of endoscopic biopsy specimen. The results showed that the prevalence of HP gastritis in group I and II were 80.4% and 56% respectively and the difference was significant statistically (p: 0.03). In group IA, the prevalence of HP infection was estimated to be 88.2%, while in group IB it was 76.5% but the difference was not significant (p: 0.31). We have not found any correlation between HbA1c levels and the presence of HP infection in both group IA and IB (p values 0.26 and 0.15 respectively). We conclude that the prevalence of HP gastritis is higher in asymptomatic diabetic patients compared with healthy people. But there is no association between the alterations in GET and the presence of HP gastritis as indicated by our results. So prolonged GET may not be regarded as a specific pathogenic mechanism or a cause of HP infection in NIDDM patients.
幽门螺杆菌(HP)是无糜烂性非特异性胃炎最常见的病因。胃溃疡和十二指肠溃疡均被发现与HP感染有关。HP感染的另一个后果是它可能进展为慢性萎缩性胃炎,而慢性萎缩性胃炎是公认的胃癌危险因素。因此,由此推断,HP感染可被视为胃癌的一个危险因素。从这方面来看,识别风险群体变得越来越重要。众所周知,糖尿病患者更容易感染。除此之外,糖尿病胃轻瘫的存在可能导致上消化道(GI)细菌过度生长。本横断面研究旨在研究上消化道动力改变的糖尿病患者中HP感染的情况,并将结果与健康对照组进行比较。第一组由51例无任何消化不良症状的II型糖尿病患者(根据国家数据组标准定义)组成。25名年龄匹配的健康人作为第二组的对照组。使用放射性核素标记的固体餐来计算胃排空时间(GET)。根据结果,第一组患者被分为两组。胃排空时间延长的患者被归为IA组,而IB组由胃排空时间正常或缩短的患者组成。HP胃炎的存在通过内镜活检标本的组织病理学检查来确定。结果显示,第一组和第二组中HP胃炎的患病率分别为80.4%和56%,差异具有统计学意义(p:0.03)。在IA组中,HP感染的患病率估计为88.2%,而在IB组中为76.5%,但差异不显著(p:0.31)。我们在IA组和IB组中均未发现糖化血红蛋白(HbA1c)水平与HP感染之间存在任何相关性(p值分别为0.26和0.15)。我们得出结论,无症状糖尿病患者中HP胃炎的患病率高于健康人。但根据我们的结果,胃排空时间的改变与HP胃炎的存在之间没有关联。因此,胃排空时间延长可能不被视为非胰岛素依赖型糖尿病(NIDDM)患者中HP感染的特定致病机制或原因。